Systems and methods for remotely monitoring hospital patients are provided. Medical devices may capture biometric data associated with a patient positioned in an ICU environment, and a remote display device positioned external to the ICU environment may display an indication of the health of the patient based on the captured biometric data. The indication of the health of the patient may include a graph mapping normalized health statuses associated with the patient over time. Each normalized health status may be based on normalizing a particular type of biometric data based on a medical protocol, so each data point of the graph includes an indication of a normalized health status associated with the patient at a given time. The indication of the health of the patient may include an animated three-dimensional that is dynamically updated to reflect biometric data associated with the patient captured at a time selected by a user.

The present invention relates to a decision support system (DSS), a medical monitoring system (100), and a corresponding method for identifying the need for measurement of cardiac output (CO) based on one or more comparisons (COMP1, COMP2) in a physiological model. More specifically, for identifying when an approximated value of CO cannot be correct due to circulatory compromise and as such that another estimated or measured value of CO is required.

Techniques for wireless component monitoring are described herein. The techniques may include entering a low power mode to associate a radio frequency identification (RFID) component with a patient monitoring device within a first range. The techniques also include entering a high power mode wherein the patient monitoring device is to detect the RFID component within a second range of the patient monitoring device, wherein the second range is larger than the first range.

A ventilation device for artificial ventilation, having: —a ventilation gas source; —a ventilation conducting assembly for conducting inspiratory ventilation gas from the ventilation gas source to a patient-side, proximal ventilation-gas outlet opening and for conducting expiratory ventilation gas away from a proximal ventilation-gas inlet opening; —a pressure-changing assembly for changing the pressure of the ventilation gas flowing in the ventilation conducting assembly; —a control device, which is designed to control the operation of the ventilation gas source and/or the operation of the pressure-changing assembly; —an evaluation device for processing sensor signals; and —an O2 sensor assembly for determining an O2 concentration value representing the oxygen concentration of the ventilation gas flowing in the ventilation conducting assembly, wherein the O2 sensor assembly outputs O2 sensor signals, which contain information regarding the O2 concentration value, to the evaluation device, and wherein the evaluation device is designed to determine, on the basis of the O2 sensor signals, an O2 change value representing a change in the O2 concentration value and, if the O2 change value satisfies a predefined condition, to infer degradation of the O2 sensor assembly and to output a signal.

The present disclosure discloses an intelligent screening algorithm and automatic upgrading system for congenital heart diseases of newborns based on big data. The key point of the technical solution is as follows: The intelligent screening algorithm and automatic upgrading system includes a heart sound data module, a heart sound data processing module, a blood oxygen data module, a blood oxygen data processing module, a network upgrading module, a database, an intelligent analysis module and a congenital heart disease evaluation module; the heart sound data module is configured to acquire various data of heart sounds of a newborn for centralized processing; and the heart sound data processing module is configured to process the data in the heart sound data module and extract heart sound feature parameters.

A system for carbon dioxide (CO2) removal from a circulatory system of a patient includes a medical device providing extracorporeal lung assist (ECLA) treatment to the patient through extracorporeal removal of CO2 from the patient's blood; at least one control unit controlling the operation of the medical device so as to control a degree of CO2 removal obtained by the ECLA treatment; and a bioelectric sensor detecting a bioelectric signal indicative of the patient's efforts to breathe. The at least one control unit is configured to control the operation of the medical device based on the detected bioelectric signal.

A physiological information processing apparatus includes a processor and a memory storing computer-readable instructions. When the instructions are executed by the processor, the physiological information processing apparatus obtains physiological information data indicative of physiological information of a subject, obtains a first parameter associated with a vital sign of the subject based on the physiological information data, displays a first trend graph showing temporal change in the first parameter in a first display area of a display screen of a display, obtains a second parameter associated with an autonomic nerve function of the subject based on the physiological information data, and displays a second trend graph showing temporal change in the second parameter in a second display area of the display screen. The first and second display areas are displayed next to each other such that time axes of the first and second display areas are synchronized with each other.

Systems and methods for vital sign monitors are disclosed herein. In some cases, a warning score is calculated based on first measurements of a first biological condition and second measurements of a second biological condition. In particular cases, the first measurements and the second measurements are automatically measured during the same time period. The warning score may be calculated based on an average of the first measurements and an average of the second measurements. Based on determining that the warning score is outside of a predetermined range, a clinical device may output an alert.

This disclosure relates generally to a method and a system for determining quality of PPG signal. The PPG signals are extensively used for deducing health parameters of patients to infer the physiological conditions of heart, blood pressure, breathing patterns of the patients. However, analysis based on PPG signals is extremely challenging and is accurate only on high quality PPG signals. However, the existing techniques for determining quality of PPG signal (that are collected using wearable devices) require huge training or use complicated algorithms and cannot be used for real-time analysis. The disclosed methods and system for PPG quality assessment is based on the frequency domain analysis, wherein heart and respiratory components in the frequency spectrum are used effectively to derive the quality checker metric which is further used to estimate a plurality of optimal thresholds that is used for determining the quality of PPG signals at real-time.

A urinary catheter can be retained inside the body for extended periods. A catheter mating device can connect to the catheter to move the catheter inside of the body or remove it from the body. The catheter includes: (1) a tube having a lumen and an outer surface, (2) a retainer that may have an attachment portion attached to the tube and a flap or handle-shaped structure attached to the attachment portion, wherein the retainer has a first, contracted position and a second, extended position, and (3) an bladder retention structure at the catheter's distal end, wherein the bladder retention portion may comprise a flap or a handle-shaped portion and that has a first, compressed position and a second, extended position. The retainer and/or bladder retention structure each are configured to retain the catheter in the proper position inside of a user's body.